Spok Holdings, Inc.
General ticker "SPOK" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $262.8M (TTM average)
Spok Holdings, Inc. does not follow the US Stock Market performance with the rate: -29.5%.
Estimated limits based on current volatility of 1.4%: low 10.59$, high 10.89$
Factors to consider:
- Company pays dividends (quarterly): last record date 2026-08-19, amount 0.31$ (Y11.69%)
- Total employees count: 421 (+2.7%) as of 2025
- US accounted for 98.1% of revenue in the fiscal year ended 2025-12-31
- Top business risk factors: Network rationalization impact, Labor/talent shortage/retention, Client dissatisfaction, Economic downturns and volatility, Market competition
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [10.54$, 16.34$]
- 2026-12-31 to 2027-12-31 estimated range: [10.92$, 16.74$]
Financial Metrics affecting the SPOK estimates:
- Positive: with PPE of 17.2 at the end of fiscal year the price was neutral
- Positive: 11.29 < Operating profit margin, % of 14.11
- Positive: 8.77 < Operating cash flow per share per price, % of 10.76
- Negative: -0.33 < Industry inventory ratio change (median), % of -0.11
- Positive: Interest expense per share per price, % of 0 <= 0
- Positive: 69.38 < Shareholder equity ratio, % of 71.02 <= 81.92
- Positive: Inventory ratio change, % of -0.81 <= -0.37
- Positive: -6.44 < Industry operating cash flow per share per price (median), % of -1.06
Short-term SPOK quotes
Long-term SPOK plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $139.03MM | $137.65MM | $139.71MM |
| Operating Expenses | $117.80MM | $118.69MM | $120.00MM |
| Operating Income | $21.23MM | $18.96MM | $19.71MM |
| Non-Operating Income | $1.10MM | $1.07MM | $1.73MM |
| R&D Expense | $10.68MM | $11.69MM | $12.22MM |
| Income(Loss) | $22.32MM | $20.03MM | $21.44MM |
| Taxes | $6.66MM | $5.07MM | $5.56MM |
| Net Income(Loss)* | $15.67MM | $14.96MM | $15.88MM |
| Stockholders Equity | $163.77MM | $154.75MM | $146.38MM |
| Assets | $227.68MM | $217.10MM | $206.11MM |
| Operating Cash Flow | $26.18MM | $28.92MM | $28.95MM |
| Capital expenditure | $3.42MM | $3.21MM | $3.75MM |
| Investing Cash Flow | $-3.42MM | $-3.21MM | $-3.05MM |
| Financing Cash Flow | $-26.68MM | $-28.54MM | $-29.79MM |
| Earnings Per Share** | $0.79 | $0.74 | $0.77 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.